Expertise in
5
conditions

Susan S. Gau-Fen Gau

No. 7 Chung Shan South Road, 
TPQ, TW 
Expertise in
5
conditions
No. 7 Chung Shan South Road, 
TPQ, TW 
OverviewLocationsClinical Research

Overview

Susan Gau-Fen Gau practices in Taiwan. Ms. Gau-Fen Gau is highly rated in 5 conditions, according to our data. Her top areas of expertise are Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder, Asperger's Syndrome, and Drug Induced Dyskinesia.

Her clinical research consists of co-authoring 268 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

No. 7 Chung Shan South Road, TPQ 10002, Taiwan
Other Locations
No. 7, Chung Shan South Road, TPQ, Taiwan
No. 8, Chung Shan South Road, TPQ, Taiwan
1, Changde Street, Zhongzheng District, TPQ 10048, Taiwan
7, Chung Shan South Road, TPQ 10002, Taiwan
Chung Shan South Road, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD), Part II
A Phase II Tolerability and Efficacy Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD), Part II
Enrollment Status: Completed
Publish Date: August 09, 2024
Intervention Type: Drug
Study Drug: PDC-1421
Study Phase: Phase 2
An Extension Study to Evaluate the Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
An Extension Study to Evaluate the Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
Enrollment Status: Completed
Publish Date: December 15, 2021
Intervention Type: Drug
Study Phase: Phase 3
Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in Attention-deficit Hyperactivity Disorder
Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in Attention-deficit Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: September 05, 2021
The Association Between Executive Functions and Candidate Genes of Dopaminergic and Noradrenergic Systems in Attention-deficit Hyperactivity Disorder
The Association Between Executive Functions and Candidate Genes of Dopaminergic and Noradrenergic Systems in Attention-deficit Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: September 05, 2021
Adult Outcome of Children With Attention-deficit/Hyperactivity Disorder
Adult Outcome of Children With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: September 05, 2021
The Effectiveness of Atomoxetine on Brain Imaging, Neuropsychological, and Social Functions in Adults With Attention Deficit/Hyperactivity Disorder
The Effectiveness of Atomoxetine on Brain Imaging, Neuropsychological, and Social Functions in Adults With Attention Deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: September 05, 2021
Structural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of Attention-deficit Hyperactivity Disorder
Structural and Functional Connectivity of Frontostriatal and Frontoparietal Networks as Endophenotypes of Attention-deficit Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: September 02, 2021
Behavior, Neuropsychology, Neuroimage and Electrophysiology in Autistic Individuals With and Without Copy Number Variation and Their Unaffected Siblings
Behavior, Neuropsychology, Neuroimage and Electrophysiology in Autistic Individuals With and Without Copy Number Variation and Their Unaffected Siblings
Enrollment Status: Completed
Publish Date: September 02, 2021
Clinical, Environmental, Neurocognitive, Brain Imaging, and Genetic Validity of Autism and Attention-deficit Hyperactivity Disorder
Clinical, Environmental, Neurocognitive, Brain Imaging, and Genetic Validity of Autism and Attention-deficit Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: September 02, 2021
Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder
Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: September 02, 2021
Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood
Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood
Enrollment Status: Completed
Publish Date: September 02, 2021
Clinical and Genetic Study of Autism Spectrum Disorder
Clinical and Genetic Study of Autism Spectrum Disorder
Enrollment Status: Completed
Publish Date: May 07, 2021
Endophenotype, Molecular Genetic Study on Attention-deficit/ Hyperactivity Disorder
Endophenotype, Molecular Genetic Study on Attention-deficit/ Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: May 07, 2021
View 12 Less Clinical Trials

268 Total Publications

All-Cause Mortality and Specific Causes of Death in Autism: A Nationwide Analysis.
All-Cause Mortality and Specific Causes of Death in Autism: A Nationwide Analysis.
Journal: Autism in adulthood : challenges and management
Published: March 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gau-Fen Gau's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile